Replies to post #352 on Rexahn Pharmaceuticals, Inc. (REXN)

[senderos]

Really, really good news.

[es1]

I would expect to hear something from this. Maybe I am wrong.


Rexahn Pharmaceuticals to Present Data on Novel Anti-Cancer Small Molecule RX-8243 at the American Association for Cancer
8:00 AM ET 4/15/10 | BusinessWire

Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage pharmaceutical company developing potential best in class oncology and central nervous system (CNS) therapeutics, today announced that it will present pre-clinical data on its anticancer compound RX-8243 at the American Association for Cancer Research (AACR) 101st Annual Meeting, held in Washington, D.C., April 17-21, 2010, at the Walter E. Washington Convention Center.